Commentary

Spontaneous abortion and antidepressants


 

When we see large studies with large numbers of patients, while exciting, we need to be more critical in interpreting the results, paying attention to the comparison groups and whether the study adjusts for the variables that can be very relevant to the outcome of interest.

Dr. Cohen is the director of the Center for Women’s Mental Health at Massachusetts General Hospital in Boston, which provides information about reproductive mental health at www.womensmentalhealth.org. He has been a consultant to manufacturers of antidepressant medications, and the Danish study was funded with one of the author’s post doc grants from the Danish Council for Independent Research Companies. To comment, e-mail him at obnews@frontlinemedcom.com.

Pages

Recommended Reading

Doctors reconstruct noses, create vaginas using engineered human tissue
MDedge ObGyn
Asymptomatic stage 2 pelvic organ prolapse seldom progresses
MDedge ObGyn
Simpler language improved patients’ recall of mesh-related risks
MDedge ObGyn
Menopause doesn’t drive severe asthma
MDedge ObGyn
Increasing maternal BMI raises fetal, infant death risk
MDedge ObGyn
VIDEO: Some SSRIs are better than others for pregnant women
MDedge ObGyn
More conclusive link needed on teratogenicity and atypicals in pregnancy
MDedge ObGyn
Hereditary cancer syndromes
MDedge ObGyn
Acetazolamide improved vision in patients with high intracranial pressure
MDedge ObGyn
Survey: 69% support ACA’s contraceptive mandate
MDedge ObGyn